SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-008998
Filing Date
2018-11-08
Accepted
2018-11-08 16:03:25
Documents
74
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q osmt-20180930x10q.htm 10-Q 2164765
2 EX-31.1 osmt-20180930ex3116e943b.htm EX-31.1 12646
3 EX-31.2 osmt-20180930ex312120c13.htm EX-31.2 12616
4 EX-32.1 osmt-20180930ex3214222df.htm EX-32.1 10154
5 EX-32.2 osmt-20180930ex322149986.htm EX-32.2 11230
  Complete submission text file 0001558370-18-008998.txt   8253771

Data Files

Seq Description Document Type Size
6 EX-101.INS osmt-20180930.xml EX-101.INS 2012825
7 EX-101.SCH osmt-20180930.xsd EX-101.SCH 49068
8 EX-101.CAL osmt-20180930_cal.xml EX-101.CAL 72658
9 EX-101.DEF osmt-20180930_def.xml EX-101.DEF 186703
10 EX-101.LAB osmt-20180930_lab.xml EX-101.LAB 432194
11 EX-101.PRE osmt-20180930_pre.xml EX-101.PRE 340488
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
Osmotica Pharmaceuticals plc (Filer) CIK: 0001739426 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-38709 | Film No.: 181169624
SIC: 2834 Pharmaceutical Preparations